Processing

Please wait...

Settings

Settings

Goto Application

1. WO2013037813 - METHODS FOR PROGNOSIS OF DIFFUSE LARGE B-CELL LYMPHOMA

Publication Number WO/2013/037813
Publication Date 21.03.2013
International Application No. PCT/EP2012/067815
International Filing Date 12.09.2012
Chapter 2 Demand Filed 11.07.2013
IPC
G01N 33/574 2006.01
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33Investigating or analysing materials by specific methods not covered by groups G01N1/-G01N31/131
48Biological material, e.g. blood, urine; Haemocytometers
50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
53Immunoassay; Biospecific binding assay; Materials therefor
574for cancer
CPC
G01N 2333/515
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
2333Assays involving biological materials from specific organisms or of a specific nature
435from animals; from humans
475Assays involving growth factors
515Angiogenesic factors; Angiogenin
G01N 2333/70596
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
2333Assays involving biological materials from specific organisms or of a specific nature
435from animals; from humans
705Assays involving receptors, cell surface antigens or cell surface determinants
70596Molecules with a "CD"-designation not provided for elsewhere in G01N2333/705
G01N 2800/52
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
2800Detection or diagnosis of diseases
52Predicting or monitoring the response to treatment; Prognosis
G01N 33/57407
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
48Biological material, e.g. blood, urine
50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
53Immunoassay; Biospecific binding assay; Materials therefor
574for cancer
57407Specifically defined cancers
Applicants
  • EUROPATH BIOSCIENCES, S.L. [ES]/[ES] (AllExceptUS)
  • FUNDACIÓ CLINIC PER A LA RECERCA BIOMÈDICA (FCRB) [ES]/[ES] (AllExceptUS)
  • DONOVAN, Michael J. [IE]/[ES] (UsOnly)
  • ERILL SAGALÉS, Nadina [ES]/[ES] (UsOnly)
  • COLOMER VALERO, Anna [ES]/[ES] (UsOnly)
  • PUIG, Pere [ES]/[ES] (UsOnly)
  • CAMPO, Elías [ES]/[ES] (UsOnly)
  • COLOMO, Luis [ES]/[ES] (UsOnly)
Inventors
  • DONOVAN, Michael J.
  • ERILL SAGALÉS, Nadina
  • COLOMER VALERO, Anna
  • PUIG, Pere
  • CAMPO, Elías
  • COLOMO, Luis
Agents
  • ARIAS SANZ, Juan
Priority Data
11382290.212.09.2011EP
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) METHODS FOR PROGNOSIS OF DIFFUSE LARGE B-CELL LYMPHOMA
(FR) MÉTHODES DE PRONOSTIC DU LYMPHOME DIFFUS À GRANDES CELLULES B
Abstract
(EN)
The method for prognosis of a patient suffering from diffuse large B-cell lymphoma (DLBCL) comprises determining in a sample from said patient the level of at least one biomarker selected from the group consisting of VEGF, BCL6, CD68, CD20, and combinations thereof.
(FR)
La présente invention concerne une méthode de pronostic du lymphome diffus à grandes cellules B (LDGCB) chez un patient en souffrant, la méthode comprenant la détermination, dans un échantillon prélevé sur le patient, du taux d'au moins un biomarqueur choisi dans le groupe comprenant VEGF, BCL6, CD68, CD20 et leurs combinaisons.
Also published as
Latest bibliographic data on file with the International Bureau